Mebendazole is a medication of the benzimidazole family used to treat a number of parasitic worm infestations, including ascariasis, pinworm infection, hookworm infections, guinea worm infections and hydatid disease, taken orally. It works by binding to the colchicine binding site of beta-tubulin in the parasite's intestinal cells, blocking the polymerization of tubulin into microtubules and gradually immobilizing and killing the worm. The Belgian pharmaceutical company Janssen Pharmaceutica developed mebendazole, which entered medical use in 1971; it is now available as a generic medication and appears on the World Health Organization's List of Essential Medicines.
Facts
Mechanism of ActionInhibits microtubule formation by binding the colchicine binding site of beta-tubulin, blocking polymerization of tubulin dimers in the intestinal cells of parasites 1 Approved UseTreatment of a number of parasitic worm infestations 1 First Approved / Isolated Year Significant RiskIn rare cases a dangerously low white blood cell count (risk of agranulocytosis), low platelet count and hair loss 1 Classification
Approval Status ATC ClassSourced to the subject's own accountP: Antiparasitic Products, Insecticides and Repellents 2 Route of Administration WHO Essential MedicineSourced to the subject's own account Sources
1. Mebendazole - Wikipedia
Article body, sentence beginning 'Mebendazole works by effectively inhibiting the formation of microtubules'
via binding to the colchicine binding site of β-tubulin, thereby blocking polymerization of tubulin dimers in intestinal cells of parasites
Lead section, first sentence
is a medication used to treat a number of parasitic worm infestations
Article body, sentence beginning 'Mebendazole came into use in 1971'
Mebendazole came into use in 1971, after it was developed by Janssen Pharmaceutica in Belgium.
Article body, sentence beginning 'In rare cases, it has been associated with'
In rare cases, it has been associated with a dangerously low white blood cell count, low platelet count, and hair loss, with a risk of agranulocytosis in rare cases.
https://en.wikipedia.org/wiki/Mebendazole, lead section
ent of giardiasis but is not a preferred agent. It is taken by mouth.
- Regulatory approval status
View the Source2. Anatomical Therapeutic Chemical Classification System (Wikipedia)
WikipediaFirst-level anatomical group codes, Code PQuote, First-level anatomical group codes, Code P
Antiparasitic products, insecticides and repellents
View the Source 3. Wikipedia
Wikipedia contributors, Wikimedia Foundation
4. WHO Model List of Essential Medicines (Wikipedia)
WikipediaWHO Model List of Essential Medicines, Intestinal anthelminthics sectionQuote, WHO Model List of Essential Medicines, Intestinal anthelminthics section
Mebendazole
View the Source 5. Mebendazole - Columbia Doctors Health Library
Drug information, opening description of the medicationQuote, Drug information, opening description of the medication
a class of medications called anthelmintics
View the Source Reader Challenges (0)
No disputes yet. Spotted an error or a better source? Open the first one.
Sign in to dispute this or suggest a correction.